Healthcare in a Changing Climate 2025

46. European Centre for Disease Prevention and Control (ECDC). (2024). Worsening spread of mosquito-borne disease outbreaks in EU/EEA, according to latest ECDC figures. https://www.ecdc.europa.eu/en/news-events/worsening-spread- mosquito-borne-disease-outbreaks-eueea-according-latest-ecdc-figures. 47. Halstead, S. (2024). Three Dengue Vaccines — What Now? The New England Journal of Medicine, vol. 390, no. 5, pp. 464-465. https://www.nejm.org/doi/full/10.1056/NEJMe2314240. 48. Jiansheng Lu et al. (2022). A human monoclonal antibody to neutralize all four serotypes of dengue virus derived from patients at the convalescent phase of infection. Virology, vol. 576, pp74-82. https://www.sciencedirect.com/science/ article/pii/S004268222200160X. 49. Walinski, A., Sander, J., Gerlinger, G., Clemens, V., Meyer-Lindenberg, A. & Heinz, A. (2023). The Effects of Climate Change on Mental Health. Deutsches Ärzteblatt International, PubMed Central, vol. 120, no. 8, pp. 117-124. https://pmc.ncbi.nlm.nih.gov/articles/PMC10154789/. 50. Eitelwein, O., Fricker, R., Green, A. & Racloz, A. (2024). The Impact Of Climate Change On Human Health. Oliver Wyman. https://www.oliverwyman.com/our-expertise/insights/2024/jan/quantifying-climate-change-impact-on-human-health.html. 51. Meek, W. (2024). Generalized Anxiety Disorder: Causes and Risk Factors. Verywell Mind. https://www.verywellmind.com/ gad-causes-risk-factors-1392982#toc-how-life-experiences-contribute-to-gad. 52. Walinski, A., Sander, J., Gerlinger, G., Clemens, V., Meyer-Lindenberg, A. & Heinz, A. (2023). The Effects of Climate Change on Mental Health. Deutsches Ärzteblatt International, PubMed Central, vol. 120, no. 8, pp. 117-124. https://pmc.ncbi.nlm.nih.gov/articles/PMC10154789/. 53. Eitelwein, O., Fricker, R., Green, A. & Racloz, A. (2024). The Impact Of Climate Change On Human Health. Oliver Wyman. https://www.oliverwyman.com/our-expertise/insights/2024/jan/quantifying-climate-change-impact-on-human-health.html. 54. Eitelwein, O., Fricker, R., Green, A. & Racloz, A. (2024). The Impact Of Climate Change On Human Health. Oliver Wyman. https://www.oliverwyman.com/our-expertise/insights/2024/jan/quantifying-climate-change-impact-on-human-health.html. 55. Eitelwein, O., Fricker, R., Green, A. & Racloz, A. (2024). The Impact Of Climate Change On Human Health. Oliver Wyman. https://www.oliverwyman.com/our-expertise/insights/2024/jan/quantifying-climate-change-impact-on-human-health.html. 56. Eitelwein, O., Fricker, R., Green, A. & Racloz, A. (2024). The Impact Of Climate Change On Human Health. Oliver Wyman. https://www.oliverwyman.com/our-expertise/insights/2024/jan/quantifying-climate-change-impact-on-human-health.html. 57. Eitelwein, O., Fricker, R., Green, A. & Racloz, A. (2024). The Impact Of Climate Change On Human Health. Oliver Wyman. https://www.oliverwyman.com/our-expertise/insights/2024/jan/quantifying-climate-change-impact-on-human-health.html. 58. Evaluate. (2024). World Preview 2024 – Pharma’s Growth Boost. https://www.evaluate.com/thought-leadership/world- preview-2024-report/. 59. Alvarado, D. (2022). Novartis to invest $250M in tropical disease drug research. Biopharma Dive. https://www.biopharmadive.com/news/novartis-kigali-neglected-tropical-disease-drug-research/625928/. 60. Grover, N. & Rigby, J. (2022). GSK, Novartis pledge funds for diseases that mostly affect the poor. Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-novartis-pledge-funds-diseases-that-mostly-affect- poor-2022-06-23/. 61. Roche. (2023). A year of meaningful impact. Annual report. https://www.roche.com/investors/annualreport23. 62. Blair, H.A. (2024). Insulin Icodec: First Approval. BioDrugs, PubMed, vol. 38, no. 5, pp. 717-724. https://pubmed.ncbi. nlm.nih.gov/39031321/. 63. Daroudi, R., Akbari Sari, A., Nahvijou, A. & Faramarzi, A. (2021). Cost per DALY averted in low, middle- and high- income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds. Cost Effectiveness and Resource Allocation, PubMed Central, vol. 19, no. 7. https://pmc.ncbi.nlm.nih.gov/articles/ PMC7863358/. 64. Roche. (2022). Limited awareness and access to cervical cancer diagnosis and treatment. https://www.roche.com/ stories/fighting-cervical-cancer . 65. Fresenius Kidney Care. (2024). Resources For Living Well With Kidney Disease. https://www.freseniuskidneycare.com/ tools-and-resources. 66. Fresenius Medical Care. (2017). How We Respond to Disasters. https://fmcna.com/content/dam/fmcna/live/company/ documents/FMCNA_PR_DisasterOverview_2017.pdf. 67. Novo Nordisk. (2023). Novo Nordisk announces new partnership to supply human insulin to millions of people living with diabetes in the African continent. https://www.novonordisk.com/content/nncorp/global/en/news-and-media/latest-news/ new-partnership-to-supply-human-insulin.html. 68. Novo Nordisk. (2024). Our position on medicine pricing. https://www.novonordisk.com/sustainable-business/access- and-affordability/pricing-position.html. 69. Roche. (2024). Phelophepa Healthcare Train. https://www.roche.co.za/about/sustainability/phelophepa-healthcare-train. 70. Deloitte. (2023). 2023 Global Life Sciences Outlook. https://www.deloitte.com/na/en/Industries/life-sciences-health-care/ perspectives/global-life-sciences-sector-outlook.html. 71. Gupta, A., Dialynas, C., McLaughlin, M. & Richie, J. (2024). Advancing Innovative Treatments for Mental Health Care. Milken Institute. https://milkeninstitute.org/sites/default/files/2024-04/AdvancingInnovativeTreatmentsMentalHealthCare.pdf. Healthcare in a Changing Climate: Investing in Resilient Solutions 43